Endoscopy Devices Market Size, Share, Growth Analysis, By Product(Endoscope(Flexible Endo scopes, Rigid Endoscopes, Disposable Endoscopes, Capsule Endoscopes), By End Use(Hospitals, Ambulatory Surgery Centers/Clinics, Other End Users), By Application(Gastrointestinal Endoscopy, Laparoscopy, Obstetrics/Gynaecology Endoscopy, Arthroscopy), By Region - Industry Forecast 2024-2031

Global Endoscopy Devices Market size was valued at USD 46.67 billion in 2022 and is poised to grow from USD 50.22 billion in 2023 to USD 90.23 billion by 2031, growing at a CAGR of 7.6% during the forecast period (2024-2031). 

The competitive landscape in the endoscopy devices market is intense, driven by rapid technological advancements and increasing demand for low-cost diagnostic solutions. Endoscopy devices constantly innovating to maintain their competitive edge through expansion and areas of application these companies invest heavily in R&D to develop high-resolution. The increasing presence of smaller specialist companies providing disposable endoscopes increases competitive pressures, especially as healthcare providers place higher priority on infection control and operational efficiency. This dynamic environment fosters innovation continuous production, with companies trying to meet medical needs and respond to changing regulatory standards, shapes the market. 'Medtronic (US) ', 'Johnson & Johnson (US) ', 'Olympus Corporation (Japan) ', 'Fujifilm Holdings Corporation (Japan) ', 'Stryker Corporation (US) ', 'Karl Storz SE & Co. KG (Germany) ', 'Boston Scientific Corporation (US) ', 'Cook Medical (US) ', 'Smith & Nephew plc (UK) ', 'Hoya Corporation (Japan) ', 'CONMED Corporation (US) ', 'Pentax Medical (Japan) ', 'Richard Wolf GmbH (Germany) ', 'B. Braun Melsungen AG (Germany) ', 'Olympus Medical Systems Corp. (Japan) ', 'Fujifilm Medical Systems USA, Inc. (US) ', 'Medtronic plc (Ireland) ', 'KARL STORZ Endoscopy-America, Inc. (US) ', 'Arthrex, Inc. (US) ', 'Ethicon, Inc. (US) '

Increasing incidence of chronic diseases such as gastrointestinal disorders, cancer, cardiovascular diseases is a key driver of endoscopy devices market. These health issues often require specific, manageable diagnostic and treatment strategies better through less invasive endoscopic techniques. Endoscope devices offer solutions that reduce relief time, reduce scarring and minimize the risks associated with open procedures. Besides, when global awareness of disease of early detection rises, the demand for accurate diagnostic devices is expected to rise, further accelerating market expansion. 

Growing demand for minimally invasive treatments: A notable feature of endoscopy devices market is the increasing preference for less invasive procedures among patients and healthcare professionals. Minimally invasive endoscopic procedures offer more advantages compared to conventional surgery such as pain relief, hospital stay shorter and faster healing time with resultant gastrointestinal tract. These techniques are becoming increasingly popular in surgeries related to the respiratory and reproductive systems. This trend is driving the demand for advanced monitoring devices anatomy that supports superior imaging and precision instrumentation, addresses the need for minimally invasive surgery and enhances patient care. 

North America dominated the endoscopy devices market in 2023, accounting for the largest revenue share at 41.0%. The high prevalence of many diseases, including gastrointestinal disorders, respiratory conditions, neurological problems, gynecological issues, and cancer, creates the need for endoscopic techniques for diagnosis and treatment disease. For example, according to a report by ResearchGate, there were estimated 2 million new cases of cancer and 611,720 cancer-related deaths in the US. in 2024. The number of candidates for minimally invasive procedures in various medical specialties including gastroenterology, nephrology, neurology, gynecology, and otolaryngology in the US. is driving demand for endoscopy. Also, the increasing prevalence of cancer, the increasing number of elderly populations, which is prone to chronic diseases requiring endoscopic treatment, and the increasing need for timely & early diagnosis will enter is leading to a search for endoscopy. About 26,890 new cases of stomach cancer and about 10,880 deaths from stomach cancer are expected in 2024, according to the American Cancer Society.